NewsRx

Search our medical news database

Regulatory Actions

Terapia Ranbaxy Receives Gmp Certificate Renewal From National Agency of Medicine for Bucharest Site

Published in Drug Law Weekly, April 17th, 2007

Following an inspection conducted by the National Agency of Medicine, the Bucharest based production facility of Terapia Ranbaxy has received a renewal of certification for Good Manufacturing Practice standards at the operational level. The inspection was carried out within the procedural three years time frame and ended-up with the release of the authorization for another three years.

"At the Bucharest site, we manufacture over 60 products comprising liquids (drops, syrups and ophthalmic solutions) and solids. We have more than 100 highly qualified specialists working at this site who have worked to very high standards and have cooperated extremely well with the...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook